Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
2seventy bio, Inc. - Common Stock
(NQ:
TSVT
)
4.510
+0.110 (+2.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 2seventy bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
Via
Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
August 15, 2023
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for 2seventy bio's Future
August 15, 2023
Via
Benzinga
Where 2seventy bio Stands With Analysts
July 28, 2023
Via
Benzinga
2seventy bio: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
August 14, 2023
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
August 09, 2023
On Wednesday, 155 companies set new 52-week lows.
Via
Benzinga
2seventy bio to Report Second Quarter 2023 Financial Results on August 14, 2023
August 08, 2023
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
August 02, 2023
During Wednesday's trading, 103 companies set new 52-week lows.
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
2seventy bio to Participate in 2023 Wedbush PacGrow Healthcare Conference
August 01, 2023
From
2seventy bio
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
On Tuesday, 46 stocks hit new 52-week lows.
Via
Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
June 20, 2023
The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Cancer Drug Trials Put On Hold After Patients Died
June 17, 2023
Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...
Via
Benzinga
2seventy Bio Pauses Pediatric Blood Cancer Trial After Patient Death, Stock Plunges
June 14, 2023
2seventy Bio Inc (NASDAQ: TSVT) announced that the Phase 1 trial of the PLAT-08 study of SC-DARIC33 in Acute Myeloid Leukemia (AML), has been paused by Seattle Children's, the company's partner and...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
July 28, 2023
Via
Benzinga
2seventy Bio Stock Crumbles After A Patient Dies In Its Pediatric Cancer Study
June 14, 2023
The company is investigating whether the death is tied to the experimental drug.
Via
Investor's Business Daily
2seventy bio Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in Acute Myeloid Leukemia
June 14, 2023
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in Upcoming Investor Conference
June 07, 2023
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Presents Late-Breaking Results for SC-DARIC33, an Investigational CD33-Targeting CAR T in Pediatric and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia
May 19, 2023
From
2seventy bio
Via
Business Wire
2seventy bio Presents Broad Range of New Data Highlighting Novel Approaches Across its Cell Therapies Portfolio
May 17, 2023
From
2seventy bio, Inc.
Via
Business Wire
Benzinga Pro's Top 5 Stocks To Watch For Friday, May 12, 2023: CMCSA, KR, ON, TSVT, CMND
May 12, 2023
Comcast (CMCSA) - The parent company of NBCUniversal. One of Friday's most-discussed stories stemmed from a tweet by Elon Musk he had found a new exec to file the chief exec role at Twitter.
Via
Benzinga
2seventy bio Announces Additional Data from KarMMa Studies of Abecma (idecabtagene vicleucel) at ASCO 2023 and EHA 2023
May 11, 2023
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
May 03, 2023
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Present New Preclinical and Clinical Data from Broad Portfolio of Investigational Cell Therapies at the ASGCT 26th Annual Meeting
May 02, 2023
From
2seventy bio
Via
Business Wire
2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program
May 01, 2023
From
2seventy bio
Via
Business Wire
2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023
April 28, 2023
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 21, 2023
During Friday's session, 149 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.